BioSpace News Archive

Program Pairs GYN Patients with Trained Advocates Who Assist with Clinical, Emotional and Financial Aspects of Surgical Care

Incyte Corporation announced that it will present at the J. P. Morgan 38th Annual Healthcare Conference on Monday, January 13, 2020 at 8:30 am in San Francisco..

Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the completion of a $50 million financing from both new and existing investors.

Aphios Corporation today announced that it was granted United States Patent No. 10,485,766 for the oral administration of Bryostatin-1 nanoparticles for the treatment of neurodegenerative diseases such as Huntington’s Disease, Parkinson’s disease, Multiple Sclerosis, Down syndrome and Alzheimer’s disease

NeuClone Pharmaceuticals Ltd (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced that NeuCeptin, a biosimilar candidate of Herceptin® (trastuzumab), has successfully met all primary and secondary endpoints in a Phase I clinical trial.

Global Marketing Agency Awarded for Content Excellence and Industry Reach Alongside the Biggest Names in Healthcare

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulator products for aesthetic and therapeutic indications, today announced the publication of the pooled data from two multicenter, randomized, double-blind, placebo-controlled Phase 3 studies (SAKURA 1 and SAKURA 2) evaluating Revance’s long-acting neuromodulator product, DaxibotulinumtoxinA

Company on track for clinical studies with RecoSeelTM in mild-to-moderate bleeding in 2021

Building Upon Breakthrough Innovation Recognition to Expand Use Throughout Premier

The resulting blood-based test will be used for triaging individuals testing positive in Low Dose CT lung cancer screening.